Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction impact of the new chronic kidney disease-epidemiology collaboration group formula

dc.contributor.authorMcAlister, Finlay A.spa
dc.contributor.authorEzekowitz, Justinspa
dc.contributor.authorTarantini, Luigispa
dc.contributor.authorSquire, Iainspa
dc.contributor.authorKomajda, Michelspa
dc.contributor.authorBayés Genís, Antonispa
dc.contributor.authorGotsman, Israelspa
dc.contributor.authorWhalley, Gillian A.spa
dc.contributor.authorEarle, Nikkispa
dc.contributor.authorPoppe, Katrinaspa
dc.contributor.authorDoughty, Robert N.spa
dc.contributor.authorMartínez Sellés Oliveria Soares, Manuel
dc.date.accessioned2013-11-27T17:26:36Z
dc.date.available2013-11-27T17:26:36Z
dc.date.issued2012spa
dc.description.abstractBACKGROUND: Prior studies in heart failure (HF) have used the Modification of Diet in Renal Disease (MDRD) equation to calculate estimated glomerular filtration rate (eGFR). The Chronic Kidney Disease-Epidemiology Collaboration Group (CKD-EPI) equation provides a more-accurate eGFR than the MDRD when compared against the radionuclide gold standard. The prevalence and prognostic import of renal dysfunction in HF if the CKD-EPI equation is used rather than the MDRD is uncertain. METHODS AND RESULTS: We used individual patient data from 25 prospective studies to stratify patients with HF by eGFR using the CKD-EPI and the MDRD equations and examined survival across eGFR strata. In 20 754 patients (15 962 with HF with reduced ejection fraction [HF-REF] and 4792 with HF with preserved ejection fraction [HF-PEF]; mean age, 68 years; deaths per 1000 patient-years, 151; 95% CI, 146-155), 10 589 (51%) and 11 422 (55%) had an eGFR <60 mL/min using the MDRD and CKD-EPI equations, respectively. Use of the CKD-EPI equation resulted in 3760 (18%) patients being reclassified into different eGFR risk strata; 3089 (82%) were placed in a lower eGFR category and exhibited higher all-cause mortality rates (net reclassification improvement with CKD-EPI, 3.7%; 95% CI, 1.5%-5.9%). Reduced eGFR was a stronger predictor of all-cause mortality in HF-REF than in HF-PEF. CONCLUSIONS: Use of the CKD-EPI rather than the MDRD equation to calculate eGFR leads to higher estimates of renal dysfunction in HF and a more-accurate categorization of mortality risk. Renal function is more closely related to outcomes in HF-REF than in HF-PEF.spa
dc.description.impact3.986 SJR (2012) Q1, 9/332 Cardiology and cardiovascular medicine, 35 de 1854 Medicine (miscellaneous)spa
dc.identifier.citationMcAlister, F. A., Ezekowitz, J., Tarantini, L., Squire, I., Komajda, M., Bayes-Genis, A., ..., & Doughty, R. N. (2012). Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction impact of the new chronic kidney disease-epidemiology collaboration group formula. Circulation: Heart Failure, 5(3), 309-314.spa
dc.identifier.doi10.1161/CIRCHEARTFAILURE.111.966242spa
dc.identifier.urihttp://hdl.handle.net/11268/883
dc.language.isoengspa
dc.peerreviewedSispa
dc.relation.publisherversionhttps://doi.org/10.1161/CIRCHEARTFAILURE.111.966242spa
dc.rights.accessRightsopen accessen
dc.subject.unescoEnfermedad cardiovascularspa
dc.titleRenal dysfunction in patients with heart failure with preserved versus reduced ejection fraction impact of the new chronic kidney disease-epidemiology collaboration group formulaspa
dc.typejournal articlespa
dspace.entity.typePublication
relation.isAuthorOfPublicationa14a4cbe-6878-47e7-8b7b-ffdd4a82573a
relation.isAuthorOfPublication.latestForDiscoverya14a4cbe-6878-47e7-8b7b-ffdd4a82573a

Files